Peptide Decoding
New?New to peptides?Start here →
Decoding

Adipotide_Dosage, benefits & legal status

Also known as FTPP, prohibitin-targeting peptide, Adipotide FTPP

Published July 22, 2026 · Updated September 22, 2026

An experimental fat-loss peptide considered dangerous, with no safe human use.

Fat loss (extreme)Proapoptotic peptideResearch onlyHigh-risk
Common vial size5 mg
Dose0.03 mg/kg per day
FrequencyDaily for 28 days in the trial
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledNo schedule exists

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Adipotide?

Plain language first. The technical label stays, but it never stands alone.

Overview

It starves fat of its blood supply. That caused dramatic fat loss in animals, but it also damaged their kidneys. It is considered dangerous, with essentially no safe human use.

The technical version

Adipotide is an experimental peptide that homes to the blood vessels feeding fat tissue and triggers them to die.

What it's used for

An experimental fat-loss peptide that cuts off the blood supply to fat tissue, with dramatic fat loss in animals.

02

How does Adipotide work?

What it does in the body, and where.

Adipotide does not affect metabolism at all. It kills the blood supply that fat tissue depends on, and that difference is the whole story.

  1. 01
    It homes to blood vessels feeding fat tissue
    One half of the molecule finds a marker found on those vessels specifically.
  2. 02
    The other half triggers those vessels to die
    A pro-apoptotic sequence that destroys the cell it has been delivered into.
  3. 03
    Fat tissue is starved of blood supply
    Obese monkeys lost substantial weight rapidly, which is why it drew attention.
  4. 04
    Kidneys were damaged in the same studies
    The kidney has a dense vascular bed and was affected too. The phase 1 human trial was terminated.
  5. 05
    It is here for reference, not as an option
    A compound designed to kill blood vessels, which did damage kidneys, and which no human trial has shown to work.
Anatomical illustration highlighting fat-metabolism
WHERE THIS COMPOUND IS THOUGHT TO ACT:
Fat

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Rapid fat loss by cutting off the blood supply to fat tissueResearch only
  • It caused kidney damage in animal studies and never reached meaningful human use, so nothing here is establishedResearch only

The published record

Research index

3

Papers and trials about Adipotide

Searched: Adipotide.

Left out: FTPP (too short to disambiguate without context).

2 papers tagged human · 2 not reviews or lab · 0 clinical trial publications

Furthest stage reached: No clinical trial on record

Compare this against the whole library →

In animals3
In the lab0
Reviews0
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count.

Adipotide vial rendering
Compound field notes

At a glance

Four things to know about Adipotide

01

Evidence

Research only

02

Category

Weight loss and metabolic

03

Common vial

5 mg

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

0.03 mg/kg per day, daily for 28 days in the trial. No schedule exists No range

Never given to people under any published protocol. The 28-day primate study found dose-dependent kidney damage, and development did not continue past a 2012 announcement of first human dosing. There is no cycle because there is no established use.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

Nothing published. The mouse and monkey work reported weight change rather than how fast the compound cleared.

You can compare this against the whole library to see where it sits.

06

How is it given?

Dosing context and source notes.
No draw available

The only human trial listed a starting dose of 0.03 mg per kg under the skin, once a day for 28 days, in men with metastatic prostate cancer and obesity. Body-weight dose. The calculator has no body-weight input, so it cannot produce a draw for this compound.

What it costs

Adipotide starts at $25.99 across 27 vendors, typically $7.50 – $16.50 per mg.

33 listings, last read Oct 24, 2026. Shipping and card fees are not included.

See all 33 listings →
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Adipotide keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Solubility, computed: 48% charged residues, 44% hydrophobic. Water usually sufficient.

A first-pass rule from peptide manufacturers' guidance. It does not account for disulfide bridges, salt form or how the powder was dried, and it predicts what should be easy rather than what will happen in your vial.

Who should avoid it

Check these before anything else.
  • Any kidney problem, since kidney damage was the main finding in animal studies
  • There is no established safe human use at all

Stop and get help

These are emergencies. Seek care.
  • Reduced urination, swelling, or unusual fatigue, which can signal kidney trouble
  • Signs of dehydration
  • Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing

Common effects

Expected, and usually mild.
  • Kidney strain is the primary documented risk
  • Dehydration
  • No reliable human safety data exists

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Adipotide approved?

And where the numbers on this page come from.

No. Adipotide is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    22 September 2026
  • Dose
    From published clinical trials. Not approved by a regulator for this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

Never progressed to meaningful human use. In primate studies it caused kidney damage, which is the finding that ended interest in it. There is no established safe human dose.

10

What else is like Adipotide?

Others in Fat loss without GLP-1, side by side.

If you're weighing Adipotide, it's worth reading BAM15, AICAR, and Humanin in the same class.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 3 records are indexed. Browse the records